0.00Open0.00Pre Close0 Volume0 Open Interest807.50Strike Price0.00Turnover1227.38%IV-5.54%PremiumJan 3, 2025Expiry Date42.40Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9720Delta0.0049Gamma--Leverage Ratio-574.2261Theta0.0000Rho0.00Eff Leverage0.0007Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet